Money was tight so I sold 30% of my shares at .125 then bought the full quota at .06. I mean, who wouldn’t?! The Ann Report was solid and I expect some good news regarding adjunct biomarkers and study 6 within the next few months. Investie is right, this CR now needs to light a fire under their arses re communication and development.
Ann: Entitlement Offer - Results, page-5
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.001(1.41%) |
Mkt cap ! $17.89M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.2¢ | 6.9¢ | $15.06K | 216.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49333 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 237245 | 3 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.001 ( 1.41 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.2¢ | 6.9¢ | 122704 | ||
| Last updated 14.56pm 05/06/2024 ? | |||||
| RHY (ASX) Chart |